Personalized Medicine in Cancer Diagnosis and Treatment: A Pharmacogenomics Perspective
TMP Universal Journal of Advances in Pharmaceutical Sciences · 18.03.2026 · 4 (1)
DOI: 10.69557/m7pqm387 ↗Kurz gefasst
Fachartikel in der Zeitschrift TMP Universal Journal of Advances in Pharmaceutical Sciences, online erschienen am 18.03.2026. Verfasst von Dhanashri Yadav.
Abstract (Originalsprache)
Personalized Medicine (PM) also called as precision medicine, Personalized medicine has transformed cancer diagnosis and treatment by tailoring therapeutic strategies to individual genetic, molecular and phenotypic characteristics. Personalized Medicine revolutioned oncology management in high human development, Oncologist have been able to target on individual’s cancer, Pharmacogenomics, the study of how genetic variations influence drug response, plays a central role in optimizing anticancer therapy by improving efficacy, reducing toxicity, and minimizing trial-and-error prescribing. Advances in genomic technologies and bioinformatics have enabled precise tumor profiling, identification of actionable mutations, and development of targeted therapies. This review discusses the principles of pharmacogenomics in oncology, its role in cancer diagnosis, treatment selection, dose optimization, and future prospects in personalized cancer care.
Zitieren
APA
Yadav, D. (2026). Personalized Medicine in Cancer Diagnosis and Treatment: A Pharmacogenomics Perspective. TMP Universal Journal of Advances in Pharmaceutical Sciences, 4(1). https://doi.org/10.69557/m7pqm387
Vancouver
Yadav D. Personalized Medicine in Cancer Diagnosis and Treatment: A Pharmacogenomics Perspective. TMP Universal Journal of Advances in Pharmaceutical Sciences. 2026;4(1). doi:10.69557/m7pqm387
BibTeX
@article{Yadav2026,
author = {Yadav, Dhanashri},
title = {Personalized Medicine in Cancer Diagnosis and Treatment: A Pharmacogenomics Perspective},
journal = {TMP Universal Journal of Advances in Pharmaceutical Sciences},
year = {2026},
volume = {4},
number = {1},
doi = {10.69557/m7pqm387}
}
EUVIMED